Back to company

MACURE PHARMA ApS: Financial statements 2018

CVR: 35234748

MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 10,257,349 and a net result of DKK 5,335,423 compared with DKK 8,913,444 the year before. That is a decrease of 28.7% compared with the year before. Equity amounted to DKK 10,506,680. The solvency ratio was 31%. The company had 5 employees in the financial year.

Gross Profit
10,257,349 kr.
Profit/Loss
5,335,423 kr.
Equity
10,506,680 kr.
Total Assets
33,942,095 kr.
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-10.3 mio.5.3 mio.10.5 mio.5
2017-14.4 mio.8.9 mio.12 mio.4
2016-13.3 mio.9.1 mio.5.5 mio.-
2015-680 t.407 t.823 t.-
2014-214 t.66 t.417 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on MACURE PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

MACURE PHARMA ApS: The 2017 annual report is outMay 23, 2018

MACURE PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 14,376,903, and the net result was DKK 8,913,444.

MACURE PHARMA ApS appoints new auditorMar 1, 2018

As of March 1, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MACURE PHARMA ApS.

Auditor steps down at MACURE PHARMA ApSFeb 28, 2018

As of February 28, 2018, Din Revisor Frederiksberg P/S Godkendte Revisorer has stepped down as auditor of MACURE PHARMA ApS.

About MACURE PHARMA ApS

MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity amounted to DKK 18,033,649.